On January 17, 2023 Bio-Techne Corporation (NASDAQ: TECH) reported that management will host a conference call and webcast on Thursday, February 2, 2023, at 8:00 a.m. CST to review second quarter 2023 financial results (Press release, Bio-Techne, JAN 17, 2023, https://investors.bio-techne.com/news/detail/347/bio-techne-to-host-conference-call-on-february-2-2023-to-announce-second-quarter-2023-financial-results [SID1234626283]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Access to the discussion may be obtained as follows:

Time:

8:00 a.m. CST

Date:

February 2, 2023

Dial-in:

1-877-407-9208 or 1-201-493-6784 (for international callers)

Conference ID:

13735661

Webcast:

https://viavidwebcastscom/startherejsp?ei=1594125&tp_key=12f30d96f5

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13735661.

The replay will be available from 11:00 a.m. CST on Thursday, February 2, 2023, until 11:00 p.m. CST on Thursday, March 2, 2023.